Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Search

Breadcrumb

  1. Services
  2. Life Sciences

Insights on Life Sciences

359 total results. Page 3 of 15.

Events
AHLA Annual Meeting 2023
June 26, 2023
Hillary M. Stemple

Health Care Partner Hillary Stemple will present at the American Health Law Association’s (AHLA) Annual Meeting on June 26, 2023.

Press Release
The Legal 500 US 2023 Guide Ranks ArentFox Schiff Attorneys and Practices Among Country’s Best
June 12, 2023

ArentFox Schiff is pleased to announce that 93 attorneys and 21 practices have been ranked by The Legal 500 United States 2023 guide, a nationwide analysis of law firms that provide cutting-edge and innovative advice.

Events
9th Annual IBA World Life Sciences Conference
May 31, 2023
Karen Ellis Carr, Alexander H. Spiegler

AgTech Industry Group Co-Leaders Karen Carr and Alexander Spiegler will speak at the International Bar Association’s 9th Annual IBA World Life Sciences Conference.

Alerts
Insider Trading Based on Clinical Trial Information Remains Area of Vulnerability
May 9, 2023

For decades, the Securities and Exchange Commission (SEC) and criminal prosecutors have pursued claims for insider trading in securities by persons who learn material nonpublic information about clinical drug trials.

Events
EPA Information Requests: Tips for Efficiently Responding and Avoiding Pitfalls
December 14, 2022
Andrew N. Sawula, Samuel A. Rasche

Partner Andy Sawula and Associate Sam Rasche discuss how to respond to EPA Information Requests.

Press Release
ArentFox Schiff Advises on Combination of Kindeva and Meridian
December 13, 2022

ArentFox Schiff advised Kindeva Drug Delivery in its combination with Meridian Medical Technologies.

Press Release
ArentFox Schiff Advised NorthView Acquisition Corp. in its $264M Merger with Profusa, Inc.
November 18, 2022

ArentFox Schiff represented NorthView Acquisition Corp., a publicly traded special purpose acquisition company, in its merger with Profusa, Inc., a digital health company.

Press Release
ArentFox Schiff Advises NextPlat on Two Separate Investments in Progressive Care
November 18, 2022

We represented NextPlat Corp., a global e-commerce platform company, in its strategic investments in Progressive Care Inc., a personalized healthcare services and technology company.

Press Release
ArentFox Schiff Advises GBS Inc. on Acquisition of Intelligent Fingerprinting
November 18, 2022

ArentFox Schiff advised GBS Inc. (Nasdaq: GBS) on its acquisition of Intelligent Fingerprinting Limited, including its proprietary drugs of abuse screening technology.

Election Analysis 2022
Alerts
ArentFox Schiff 2022 Election Analysis
November 10, 2022
Byron Dorgan*, Doug Jones, Philip S. English*, Dan H. Renberg, Jon S. Bouker, Craig Engle, David P. Grosso, Cissy Jackson, Oliver Spurgeon III*, Amy Antoniolli, Stephen P. Hanson, Laura E. Doyle*, Daniel Sjostedt*

Americans woke up on Wednesday, November 9, immediately realizing something was different. On their televisions and other devices, they only saw commercials for products, vacation spots, and reality shows.

Press Release
LMG Life Sciences Ranks Five Attorneys for 2022
October 20, 2022

ArentFox Schiff is pleased to announce that five attorneys have been ranked by LMG Life Sciences, which recognizes the work of outstanding individuals in the life sciences sector.

Press Release
ArentFox Schiff Guides Boustead Securities in the Know Labs $8.28M Public Offering
September 20, 2022

We represented Boustead Securities, LLC as the sole underwriter in Know Labs, Inc.’s $8.28 million public offering of common stock.

Press Release
ArentFox Schiff Uses Lanham Act Claim To Secure Victory for Azurity Pharmaceuticals
September 13, 2022

ArentFox Schiff secured an important victory for Azurity Pharmaceuticals, Inc. when the US Court of Appeals for the First Circuit found that the Food, Drug, and Cosmetic Act permits a pharmaceutical company to pursue false advertising claims against a compounding pharmacy, Edge Pharma, LLC.

Press Release
ArentFox Schiff Publishes Premier Industry Guide to the Metaverse
August 17, 2022

The Metaverse stands to disrupt nearly every industry – fashion, media and entertainment, real estate, sports, the list goes on – presenting immense possibilities and potential risks. We have created the ArentFox Schiff Industry Guide to the Metaverse to answer questions and anticipate concerns.

Press Release
ArentFox Schiff Shortlisted for LMG Life Sciences Americas Awards 2022
July 27, 2022

ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual LMG Life Sciences Americas Awards.

Alerts
Life Sciences in the Metaverse: A New Forum
July 25, 2022
Sailesh K. Patel

The life sciences and pharmaceutical industry is investigating potential applications in the Metaverse to reduce costs, increase efficiency, and develop novel functionalities.

Alerts
Drug Development in the Metaverse
June 17, 2022
Sailesh K. Patel, Matthew T. Wilkerson

“Metaverse” is no longer a mere buzzword. Many industries are discovering and developing applications for the Metaverse, and the pharma and biotech industry is no different.

Events
IBA 8th Annual World Life Sciences Conference
May 17, 2022
Alexander H. Spiegler

ArentFox Schiff Intellectual Property Partner Alex Spiegler will present at the International Bar Association (IBA) 8th Annual World Life Sciences Conference.

Alerts
Attorney-Client Privilege Issues: Three Ways Companies Can Shield Privileged Communications From Their Directors
May 4, 2022
Kirstie Brenson, Adam Diederich

Directors owe fiduciary duties to the company. To make informed decisions and satisfy those fiduciary duties, directors generally have broad access to the company’s books and records, with a few exceptions.

Press Release
ArentFox Schiff Advises on Tenon Medical’s $16M IPO
May 2, 2022

ArentFox Schiff LLP represented The Benchmark Company, LLC as underwriter in Tenon Medical, Inc.’s initial public offering. The $16 million IPO closed on April 29, 2022.

Events
Paragraph IV Disputes Conference 2022
April 26, 2022
Richard J. Berman, Sailesh K. Patel, Imron T. Aly, Kevin M. Nelson, Bradford C. Frese, Taniel E. Anderson

ArentFox Schiff is sponsoring the ACI Paragraph IV Disputes Conference and Rich Berman and Sal Patel will present.

Health Care Counsel Blog
Nevada To Begin Enforcing Pharma Sales Force Registration Law
February 23, 2022
Stephanie Trunk

Back in 2017, the state of Nevada passed a sweeping bill into law that addressed not only drug pricing transparency, but also reporting obligations applicable to pharmacy benefit managers and non-profit organizations and also imposed certain requirements on manufacturer sales forces.

Trade Secrets, Noncompetes & Employee Mobility Practice Image
Alerts
Trade Secrets 2021: Analysis of the Year’s Key Cases & Trends
February 10, 2022
Linda M. Jackson, Alexander H. Spiegler, Lauren C. Schaefer, Allan E. Anderson, Robert K. Carrol, Nicholas J. Nesgos, Alexandra M. Romero, Sara T. Schneider, Pascal Naples, Nadia Patel, Jodi Tai

Download Our Summary of the Most Important Cases.

Health Care Counsel Blog
Contract Year 2023 Part D Proposed Rule Released: Changes To 'Negotiated Price' Would Require Potential DIR Fees at the Point of Sale
January 26, 2022
Stephanie Trunk

The Centers for Medicare & Medicaid Services (CMS) published the proposed Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (the Proposed Rule) on January 12, 2022, in the Federal Register.

Alerts
Identifying Acrylamide Exposure Risks to Protect Residents of California
January 18, 2022
Lynn R. Fiorentino, Debra Albin-Riley, Brian P. Waldman, Robert G. Edwards, Ph.D.

Prop 65 Counsel: What To Know

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2025 ArentFox Schiff LLP. All Rights Reserved.

Back to Top